Skip to main content
Press Spacebar to Enter/Exit Menu
MENU
Search
Search
Main navigation
Home
About
People
News
Training Programs
Membership
Resources
Community Outreach
Contact Us
Giving
Research
Make a Gift
Quick Links
merkelcell.org
Socials
LinkedIn
Bluesky
Instagram
Breadcrumb
Home
News
Research
Page 5
of 5
Should subclinical (ctDNA positive) MCC be treated with immunotherapy? A Proposed Randomized Clinical Trial
Jan 27
January 27, 2025
Should subclinical (ctDNA positive) MCC be treated with immu…
Pagination
Previous page
Previous
Page 5
